IMARC Group values Saudi Arabia’s medical tourism market at USD 1,633.5 million for 2025 and projects USD 8,887.9 million by 2034, a compound annual growth rate of 20.71 percent. Those numbers have been doing the rounds in recycled press releases, so it is worth separating the forecast from the facts underneath it. The forecast asks you to believe a market Saudi Arabia barely had a decade ago will more than quintuple. The facts are a state health budget being rebuilt from the ground up, one flagship hospital with genuinely strong inbound numbers, and a virtual-care network no other country in the region can match.
Two research houses, one market, an eightfold gap
IMARC’s list of growth drivers is plausible enough: patients from the region who would rather be treated closer to home, wellness services sold alongside procedures, widely available health insurance, hospitals holding international accreditation, and government moves to simplify the medical visa process. The trouble starts when you put the forecast next to a rival one. Research and Markets valued the same market at USD 0.20 billion in 2024 and expects USD 0.68 billion by 2030, growing at 22.50 percent a year. IMARC’s 2025 base of USD 1.63 billion is roughly eight times larger.
Both houses cannot be right, and my reading is that neither is measuring a settled thing. One is almost certainly counting a broad basket of health and wellness travel while the other counts a narrow definition of inbound treatment. When two estimates of one national market differ by a factor of eight, the honest conclusion is that the market is too young to measure well. What is telling is that the growth rates nearly agree: both firms assume a steep climb from wherever their base happens to sit. Take the direction from the research and treat the size with suspicion.
Vision 2030 money is real, and mostly domestic
The engine behind every Saudi health headline is the Health Sector Transformation Program, one of the Vision 2030 realization programs, which commits the state to wider access, digital care and prevention rather than treatment. The US International Trade Administration’s commercial guide puts hard numbers on the effort: more than USD 65 billion earmarked for health infrastructure, a plan to privatize 290 hospitals and 2,300 primary health centers, and a reorganization of care into 21 health clusters, the first two of which are already operating in Riyadh. The 2024 health allocation alone was SAR 214 billion, about USD 57 billion, roughly 17 percent of the entire state budget. The same guide expects the total Saudi health market to reach about USD 102 billion by 2035.
Look at what that money is actually for, though, and almost none of it targets foreign patients. This is a domestic overhaul: the state is converting a public health service into a regulated market and inviting private operators to run most of it. Medical tourism rides along on the side. Privatized hospital clusters will need revenue beyond what the state pays them, and international patients are the obvious top-up. That is precisely why I take the sector seriously despite the messy market research. The hospitals get built and staffed whether or not a single foreign patient arrives; the forecasts are really a bet on who fills the beds afterwards.
The flagship already has inbound numbers
King Faisal Specialist Hospital and Research Centre used Arab Health 2025 in Dubai to show its books. Deputy chief executive Dr Bjorn Zoega reported 46,476 new patients in 2024 and a 47.39 percent rise in medical tourism cases, with patients arriving from 17 countries. The institution runs 2,443 beds across three cities and places on Newsweek’s and Brand Finance’s global hospital rankings, unusual territory for the region.
A 47 percent jump is easier to post when the base is small, and 17 source countries points to a mostly regional draw: Gulf neighbours, diaspora families, patients from nearby markets with thin specialist care. Even so, this is the first Saudi institution publishing inbound growth figures rather than ambitions, and that distinction matters. Turkey and Thailand both built their trade on a handful of flagship hospitals that proved the model before anyone else followed. KFSHRC is being groomed for exactly that role, and its willingness to publish patient numbers is the surest sign the ministry believes them.
A virtual hospital is the sharpest tool in the kit
The original version of the growth story leaned heavily on artificial intelligence, and most of those claims dissolve on contact with a source. One does not. The Ministry of Health’s Seha Virtual Hospital now supports more than 242 hospitals across 48 main specialties and 68 sub-specialties, with capacity for over 597,000 patients a year, and Guinness World Records lists it as the largest virtual healthcare provider in the world.
For medical travel the value is concrete rather than futuristic. A prospective patient in Cairo or Karachi can have local imaging reviewed by a Riyadh consultant before anyone books a flight, which removes the most expensive uncertainty in the whole exercise: travelling for a treatment you may not need or cannot get. Writing in Arab News, health tourism specialist Saad Majdy Baslom argued that the kingdom sits within a six-to-eight-hour flight of Europe, Africa and much of Asia and should compete on quality and innovation rather than price. The geography argument cuts both ways, since the same flight radius reaches Istanbul, Dubai and Delhi, all established competitors with decade-long head starts. Quality plus a working referral pipeline is the better pitch, and Seha is the pipeline.
What This Means
Strip the press-release gloss off this story and what remains is still substantial. The state is spending on health at a scale no regional rival matches, the flagship hospital has real double-digit inbound growth, and the referral infrastructure exists today rather than in a rendering. What does not exist is an agreed measure of the market: when research firms disagree by a factor of eight, every headline figure deserves a raised eyebrow, including the USD 8.9 billion one. My read is that Saudi Arabia becomes a serious treatment centre for Gulf and Muslim-majority markets well before it troubles Bangkok or Istanbul on volume, because that is the demand its geography, religious travel flows and referral network actually serve. I would watch whether the newly privatized clusters start reporting international patient numbers the way KFSHRC now does, and whether the promised medical visa simplification ships as working software rather than a slide. The forecasts will follow the plumbing, not the other way around.
